Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability

被引:247
作者
Milazzo, Giorgio [1 ]
Mercatelli, Daniele [1 ]
Di Muzio, Giulia [1 ]
Triboli, Luca [1 ]
De Rosa, Piergiuseppe [1 ]
Perini, Giovanni [1 ]
Giorgi, Federico M. [1 ]
机构
[1] Univ Bologna, Dept Pharm & Biotechnol, Via Selmi 3, I-41026 Bologna, Italy
关键词
histone deacetylases; HDAC; chromatin; epigenetics; epigenomics; HDAC inhibitors; HDACi; gene networks; cancer; phylogenesis; INHIBITOR VALPROIC ACID; CANCER STEM-CELLS; CLASS-I HDACS; 2 CATALYTIC DOMAINS; LUNG-CANCER; PHASE-I; HEPATOCELLULAR-CARCINOMA; SELECTIVE-INHIBITION; PANCREATIC-CANCER; BREAST-CANCER;
D O I
10.3390/genes11050556
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Histone deacetylases (HDACs) are evolutionary conserved enzymes which operate by removing acetyl groups from histones and other protein regulatory factors, with functional consequences on chromatin remodeling and gene expression profiles. We provide here a review on the recent knowledge accrued on the zinc-dependent HDAC protein family across different species, tissues, and human pathologies, specifically focusing on the role of HDAC inhibitors as anti-cancer agents. We will investigate the chemical specificity of different HDACs and discuss their role in the human interactome as members of chromatin-binding and regulatory complexes.
引用
收藏
页数:49
相关论文
共 331 条
[1]   Co-repressor, co-activator and general transcription factor: the many faces of the Sin3 histone deacetylase (HDAC) complex [J].
Adams, Grace E. ;
Chandru, Aditya ;
Cowley, Shaun M. .
BIOCHEMICAL JOURNAL, 2018, 475 :3921-3932
[2]   Synergistic Immunostimulatory Effects and Therapeutic Benefit of Combined Histone Deacetylase and Bromodomain Inhibition in Non-Small Cell Lung Cancer [J].
Adeegbe, Dennis O. ;
Liu, Yan ;
Lizotte, Patrick H. ;
Kamihara, Yusuke ;
Aref, Amir R. ;
Almonte, Christina ;
Dries, Ruben ;
Li, Yuyang ;
Liu, Shengwu ;
Wang, Xiaoen ;
Warner-Hatten, Tiquella ;
Castrillon, Jessica ;
Yuan, Guo-Cheng ;
Poudel-Neupane, Neermala ;
Zhang, Haikuo ;
Guerriero, Jennifer L. ;
Han, Shiwei ;
Awad, Mark M. ;
Barbie, David A. ;
Ritz, Jerome ;
Jones, Simon S. ;
Hammerman, Peter S. ;
Bradner, James ;
Quayle, Steven N. ;
Wong, Kwok-Kin .
CANCER DISCOVERY, 2017, 7 (08) :852-867
[3]  
Agarwal Saurabh, 2018, Oncotarget, V9, P20323, DOI 10.18632/oncotarget.24859
[4]   Histone deacetylase inhibitor, apicidin, inhibits human ovarian cancer cell migration via class II histone deacetylase 4 silencing [J].
Ahn, Mee Young ;
Kang, Dong O. ;
Na, Yong Jin ;
Yoon, Sungpil ;
Choi, Whan Soo ;
Kang, Keun Wook ;
Chung, Hae Young ;
Jung, Jee H. ;
Min, Do Sik ;
Kim, Hyung Sik .
CANCER LETTERS, 2012, 325 (02) :189-199
[5]   HDAC inhibitor apicidin suppresses murine oral squamous cell carcinoma cell growth in vitro and in vivo via inhibiting HDAC8 expression [J].
Ahn, Mee-Young .
ONCOLOGY LETTERS, 2018, 16 (05) :6552-6560
[6]   A NOVEL YEAST HISTONE DEACETYLASE - PARTIAL CHARACTERIZATION AND DEVELOPMENT OF AN ACTIVITY ASSAY [J].
ALONSO, WR ;
NELSON, DA .
BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 866 (2-3) :161-169
[7]   The African coelacanth genome provides insights into tetrapod evolution [J].
Amemiya, Chris T. ;
Alfoeldi, Jessica ;
Lee, Alison P. ;
Fan, Shaohua ;
Philippe, Herve ;
MacCallum, Iain ;
Braasch, Ingo ;
Manousaki, Tereza ;
Schneider, Igor ;
Rohner, Nicolas ;
Organ, Chris ;
Chalopin, Domitille ;
Smith, Jeramiah J. ;
Robinson, Mark ;
Dorrington, Rosemary A. ;
Gerdol, Marco ;
Aken, Bronwen ;
Biscotti, Maria Assunta ;
Barucca, Marco ;
Baurain, Denis ;
Berlin, Aaron M. ;
Blatch, Gregory L. ;
Buonocore, Francesco ;
Burmester, Thorsten ;
Campbell, Michael S. ;
Canapa, Adriana ;
Cannon, John P. ;
Christoffels, Alan ;
De Moro, Gianluca ;
Edkins, Adrienne L. ;
Fan, Lin ;
Fausto, Anna Maria ;
Feiner, Nathalie ;
Forconi, Mariko ;
Gamieldien, Junaid ;
Gnerre, Sante ;
Gnirke, Andreas ;
Goldstone, Jared V. ;
Haerty, Wilfried ;
Hahn, Mark E. ;
Hesse, Uljana ;
Hoffmann, Steve ;
Johnson, Jeremy ;
Karchner, Sibel I. ;
Kuraku, Shigehiro ;
Lara, Marcia ;
Levin, Joshua Z. ;
Litman, Gary W. ;
Mauceli, Evan ;
Miyake, Tsutomu .
NATURE, 2013, 496 (7445) :311-316
[8]   Mechanisms of Acquired Drug Resistance to the HDAC6 Selective Inhibitor Ricolinostat Reveals Rational Drug-Drug Combination with Ibrutinib [J].
Amengual, Jennifer E. ;
Prabhu, Sathyen A. ;
Lombardo, Maximilian ;
Zullo, Kelly ;
Johannet, Paul M. ;
Gonzalez, Yulissa ;
Scotto, Luigi ;
Serrano, Xavier Jirau ;
Wei, Ying ;
Duong, Jimmy ;
Nandakumar, Renu ;
Cremers, Serge ;
Verma, Akanksha ;
Elemento, Olivier ;
O'Connor, Owen A. .
CLINICAL CANCER RESEARCH, 2017, 23 (12) :3084-3096
[9]   Inhibition of the Autophagy Pathway Synergistically Potentiates the Cytotoxic Activity of Givinostat (ITF2357) on Human Glioblastoma Cancer Stem Cells [J].
Angeletti, Francesca ;
Fossati, Gianluca ;
Pattarozzi, Alessandra ;
Wurth, Roberto ;
Solari, Agnese ;
Daga, Antonio ;
Masiello, Irene ;
Barbieri, Federica ;
Florio, Tullio ;
Comincini, Sergio .
FRONTIERS IN MOLECULAR NEUROSCIENCE, 2016, 9
[10]  
Ansari D, 2014, ANTICANCER RES, V34, P5269